Skip to content
Tuesday 1 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,789.28
-0.32%
DAX
25,970.11
-1.10%
CAC 40
8,301.85
-0.39%
STOXX 50
6,368.98
-0.80%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Friday 16 April 2021 5:01 am  |  Updated:  Friday 16 April 2021 6:42 am

Filter that is able to remove Covid-19 from blood given emergency approval in US

By: Michiel Willems

Add as a preferred source on Google

A Pentagon-funded agency has developed a filter that is able to remove the Coronavirus from blood cells when linked to a dialysis machine.

After around 300 critically ill Covid-19 patients made a full recovery following treatment with the filter, the FDA has approved the method for emergency use, according to multiple media reports.

Moreover, scientists at the Defense Advanced Research Project Agency (DARPA) have also developed a microchip that can detect Covid-19 when inserted under the skin.

The relatively secretive team at DARPA, a unit that was created at the height of the Cold War, have reportedly been working on the project for years.

Its initial aim was to prevent and slow pandemics and virus outbreaks. The team’s efforts were ramped up and expanded following the outbreak of Coronavirus at the beginning of last year.

Covid-19 blood filter

According to 60 Minutes, aired last Sunday evening on CBS, a Covid-19 infected patient was placed on a dialysis machine, after which the virus was removed from the blood.

During the broadcast, Matt Hepburn, a retired US army colonel who leads DARPA’s infectious disease program, explained the experimental treatment lasts four days and was first given to ‘patient 16,’ a military spouse, who had ended up in intensive care with organ failure and septic shock.

“Basically, you pass it through [the filter], and it takes the virus out, and puts the blood back in,” Hepburn told viewers.

Patient 16 made a full recovery within days, according to the report.

The FDA has reportedly authorized the filter for emergency use, after it was successfully been used to treat nearly 300 critically ill patients.

Microchip

Also discussed during the 60 Minutes episode was DARPA’s microchip, which is able to detect a Covid-19 infection before the individual in question can actually transmit the virus, and thus prevent an outbreak.

During the broadcast, Hepburn demonstrated to the 60 Minutes team how a tissue-like gel can continuously monitor and test an individual’s blood.

“You put [the chip] underneath your skin and what that tells you is that there are chemical reactions going on inside the body, and that signal means you are going to have symptoms tomorrow,” Hepburn explained.

Read more

Ari Emmanuel snaps up West End theatre group ATG for £4.5bn

Paddington Bear in a blue duffle coat and red hat on a purple background with BAFTA and EE logos

“It’s like a ‘check engine’ light,” he continued, adding that “sailors would get the signal, then self-administer a blood draw and test themselves on site, [and] we can have that information in three to five minutes.”

Officials reportedly stressed that is not the Pentagon’s aim to track individuals’ movements or to collect other data from the implanted chip.

Vaccine for mutations

Finally, another scientist, Dr Kayvon Modjarrad, said during the show that he and his team are currently developing a vaccine against all Covid mutations.

“We have the tools, we have the technology, to do this all right now,” he reportedly said. ‘This is not science fiction, this is science fact.”

Ultimately, this should provide protection against deadly viruses that have not even been identified or do not even exist today, he continued.

“Killer viruses that we haven’t seen or even imagined, we’ll be protected against,” Modjarrad concluded.

Below a fragment from 60 Minutes, aired last Sunday evening.

[brid video=”756206″ player=”24372″ title=”A%20sensor%20that%20can%20tell%20you%20if%20you&#39re%20sick” duration=”79″ description=”Bill Whitaker reports on some of the innovations being developed to try to prevent the next pandemic. See the story Sunday on 60 Minutes."60 Minutes" is the …” uploaddate=”2021-04-14 02:32:20″ thumbnailurl=”https://i.ytimg.com/vi/No5Bz2eHNtA/default.jpg” contentUrl=”http://www.youtube.com/watch?v=No5Bz2eHNtA”]

Almost half of US Marines decline vaccine

The latest Pentagon tools to detect and prevent Covid-19 infections comes as it was made public that around 40 per cent of US Marines have chosen not to receive a Covid-19 vaccination.

Data provided by the service shows that as of last week, 75,500 Marines had received a vaccination, while 48,000 declined the jab.

The declination rate at the Camp Lejeune facility in North Carolina was even higher, at 57 per cent.

“We fully understand that widespread acceptance of the Covid-19 vaccine provides us with the best means to defeat the pandemic. The key to addressing the pandemic is building vaccine confidence,” Marine Corps spokeswoman Col. Kelly Frushour told CNN in a statement.

Frushour said there are several potential reasons why Marines are choosing not to have the jab, such as allowing others to receive it first or waiting until it becomes mandatory.

“Service members who decline one day can change their mind and become vaccinated when next the opportunity presents itself,” she said.

Read more

Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Morning Wire Content

Related Topics

  • Coronavirus

Trending Articles

  • Vodafone and Deliveroo look to patch up Reform ties after Yusuf prison threats

  • Jaguar reveals the Type 01’s screen-free interior

  • Trio of firms poised to quit London Stock Exchange as exodus gathers pace

  • Easyjet’s over-60s recruitment push is economically necessary

  • As it happened: FTSE 100 slides as bound rout deepens; Oil jumps as Trump vows more strikes on Iran

More from Morning Wire

  • Ari Emmanuel snaps up West End theatre group ATG for £4.5bn

    Hospitality
    Paddington Bear in a blue duffle coat and red hat on a purple background with BAFTA and EE logos
  • Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award

    Business Wire
  • PropertyStream and Offr Launch TRANSACT as UK Homebuying Enters the Digital Era

    Business Wire
  • Emergency government meeting held over high temperature amid ‘strain on public finances’

    Economics
    Aerial view of dry, brown farm fields affected by high temperatures, with a road and farm buildings.
  • There’s a 45 per cent chance this op-ed was written by AI

    Opinion
    Vintage 1960s typing gloves, showcasing retro office fashion and ergonomic design for typewriter use
  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • Everyone’s welcome: The UK holiday cottages that are truly inclusive

    Life&Style
    Modern timber-clad holiday lodge in Hampshire with a spacious deck, outdoor dining, and BBQ grill. Perfect UK staycation.
  • Europe has made a ‘major mistake’ on slow electrification, IEA chief warns 

    Energy
    UK industrial electricity prices are the highest in the G7 and 46 per cent above the average of the International Energy Agency.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook